These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7295514)

  • 21. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH; Vaitkevicius VK; Gehan E
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Laurent G; Dewerie-Vanhouche J; Machin D; Hildebrand J
    Cancer Res; 1980 Mar; 40(3):939-42. PubMed ID: 7471107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleoside analogues: 8. Some isomers of B.3839, the original 5-fluorouracil/nitrosourea molecular combination, and their effect on colon, breast and lung tumours in mice.
    McElhinney RS; McCormick JE; Bibby MC; Double JA; Atassi G; Dumont P; Pratesi G; Radacic M
    Anticancer Drug Des; 1989 Jun; 4(1):1-20. PubMed ID: 2757750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of nandrolone decanoate on the repopulation of the thymus after total body irradiation of mice.
    Plum J; Huys J; De Scheerder Y; Dhont E; De Smedt M
    Immunopharmacology; 1982 Oct; 5(1):19-30. PubMed ID: 6752097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Engstrom PF; Catalano RB; Creech RH
    Cancer Treat Rep; 1976 Mar; 60(3):285-7. PubMed ID: 1260784
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
    Douglass HO; Lavin PT; Moertel CG
    Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY; Workman P
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.
    Tejada F; Eisenberger MA; Broder LA; Cohen MH; Simon R
    Cancer Treat Rep; 1977 Nov; 61(8):1589-90. PubMed ID: 922761
    [No Abstract]   [Full Text] [Related]  

  • 31. A clinical trial of CCNU (1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea) (NSC 79037) in advanced ovarian carcinoma.
    Sasaki TM; McConnell DB; Moseley HS; Merhoff GC; Fletcher WS
    J Surg Oncol; 1975; 7(5):347-50. PubMed ID: 1100915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Some preliminary observations on chemotherapy of infantile medulloblastomas with vincristine sulfate and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)].
    Pompili A; Cianfriglia F; Occhipinti E
    Minerva Pediatr; 1978 Nov; 30(21):1721-4. PubMed ID: 723818
    [No Abstract]   [Full Text] [Related]  

  • 33. Adriamycin, CCNU, and 5-fluorouracil in patients with advanced gastrointestinal cancer.
    Cedermark BJ; Gunven P; Hammarberg C
    J Surg Oncol; 1983 Feb; 22(2):125-8. PubMed ID: 6296546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of combined chemotherapy (adriamycin/VM/26/CCNU) in brian tumours in adults and animal experiments (author's transl)].
    Ilsen HW; Petrovici IN; Mennel HD; Zülch KJ; Szymas J
    Fortschr Neurol Psychiatr; 1982 Mar; 50(3):73-90. PubMed ID: 7095717
    [No Abstract]   [Full Text] [Related]  

  • 35. Response of two mouse tumours to hyperthermia with CCNU or melphalan.
    Joiner MC; Steel GG; Stephens TC
    Br J Cancer; 1982 Jan; 45(1):17-26. PubMed ID: 7059461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraneoplastic injection of CCNU for experimental brain tumor chemotherapy.
    Tator CH
    Surg Neurol; 1977 Feb; 7(2):73-7. PubMed ID: 835077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
    Hirst DG; Brown JM; Hazlehurst JL
    Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
    Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
    Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours.
    Bibby MC; Double JA; Morris CM
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1361-4. PubMed ID: 3181257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental brain tumor chemotherapy: DNA damage in the rat gliosarcoma 9L treated with CCNU.
    Gutin PH; Hilton J; Walker MD
    Clin Neurosurg; 1977; 24():653-64. PubMed ID: 583703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.